DNMT3B and cholangiocarcinoma: This study has demonstrated that miR-29b targets and regulates expression of DNA methyltransferase 3 beta (DNMT3B), which is upregulated in CCA tumors and induces CCA growth, indicating the potential of miR-29b/DNMT3B as a therapeutic target [84].